Webinar

Highly Potent API Drug Product Development And Manufacturing Using Micronization Technology

Source: Catalent

Small molecule drug developers continue to realize the strong therapeutic potential of highly potent active pharmaceutical ingredients (HPAPIs), particularly in areas such as oncology. With this demand comes a critical need for safe manufacturing and containment technologies to produce high quality products. Micronization is a proven and widely used technology to address bioavailability and manufacturability challenges facing highly potent oral drugs. Development of HPAPIs presents unique challenges for product containment and requires special consideration in equipment selection, operating procedures and safety processes.

This webinar discusses how to classify HPAPIs in early development and share recommendations for safe product handling, from clinical manufacturing to commercialization. The speaker also shares the key advantages of using micronization technology for the development and manufacture of HPAPIs.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: